Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
Miles Horton1,2, Becky Leung3,4, Ricky Nelles3,5
1Clinical Hematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Bone Marrow Transplantation
|April 23, 2026
Abstract
No abstract available in PubMed .


